Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hair loss doesn't affect COVID-19 severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Social media data can help track and predict COVID-19 symptoms and trends.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Tocilizumab might be an effective treatment for COVID-19.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

2021 saw a slow return to normalcy and increased scientific engagement despite COVID-19 challenges.

Third booster shots enhance the immune system's response to the COVID-19 virus.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

Women are more likely to have long-term post-COVID symptoms than men.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.